Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
6.55
+0.31 (4.97%)
Nov 5, 2025, 4:00 PM EST - Market closed
Design Therapeutics Employees
Design Therapeutics had 54 employees as of December 31, 2024. The number of employees decreased by 4 or -6.90% compared to the previous year.
Employees
54
Change (1Y)
-4
Growth (1Y)
-6.90%
Revenue / Employee
n/a
Profits / Employee
-$1,175,704
Market Cap
373.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54 | -4 | -6.90% |
| Dec 31, 2023 | 58 | 0 | - |
| Dec 31, 2022 | 58 | 20 | 52.63% |
| Dec 31, 2021 | 38 | 23 | 153.33% |
| Dec 31, 2020 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DSGN News
- 13 hours ago - Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Design Therapeutics Appoints Justin Gover to Board of Directors - GlobeNewsWire
- 2 months ago - Design Therapeutics, Inc. (DSGN) Presents at Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2 - GlobeNewsWire
- 5 months ago - Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference - GlobeNewsWire